Market Overview The US anti nuclear antibody testing market is adapting as payer policies increasingly influence testing patterns through reimbursement and prior authorization requirements. The US Anti Nuclear Antibody Testing Market is projected to grow through 2030, driven by Medicare fee schedule adjustments, growing commercial payer medical necessity criteria, rising laboratory compliance...